Results 231 to 240 of about 931,588 (304)

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Emerging, challenges and modernization path of gene privacy in China: from personal privacy to group privacy. [PDF]

Philos Ethics Humanit Med
Chen J, Li W.
europepmc   +1 more source

A comparative analysis of food retail policy landscape in four Southeast Asian countries. [PDF]

Lancet Reg Health Southeast Asia
Phulkerd S, Samsiripong W, Borazon EQ, Teh WS, Saptari AF, Sameeha MJ, Fitri AA, Trisnasari S, Farrell P, Thow AM, Koon Poh B, SEAOFE Study Group.   +11 more
europepmc   +1 more source

Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements

British Journal of Clinical Pharmacology, EarlyView.
Within the ConcePTION project we set out to design two mother–infant pair studies collecting breast milk and plasma from the mother and plasma from the infant (for metformin and prednisolone) in order to demonstrate the premises and conditions for investigating potential drug transfer in association with breastfeeding.
Mats Hansson, Ida Björkgren, Jenny Svedenkrans, Helena Backman, Jarl Hellman, Linda Englund‐Ögge, Mikaela Magnusson, Inger Lindström, Andrea Wutte, Erica Sundell, Pawel Baranczewski, Laura Shaughnessy   +11 more
wiley   +1 more source

Enforcing the Canadian Prohibition of Overcrowding Livestock in Transit Without Resorting to Science. [PDF]

Animals (Basel)
Whiting TL.
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Fairness evaluation of collaborative governance of food safety in Jilin Province based on AHP-FCE model: multi-dimensional difference analysis and policy implications research. [PDF]

Front Public Health
Qi X, Chen Y, Yu X.
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Extreme Risk Protection Orders and Firearm and Nonfirearm Suicides in the US.

JAMA Health Forum
Brown TT, Kaplan MS, Yan Z, Xiao Y.
europepmc   +1 more source

Paths of legal recognition of genetic counselors in Canada: A framework for action. [PDF]

J Genet Couns
Patrinos D, Bonilha AE, Knoppers BM, Elliott AM, GenCOUNSEL Study, Zawati MH.   +5 more
europepmc   +1 more source